AccendoWave - the only company that can remotely monitor pain. Pain is the #1 reason for a hospital readmit.

A Health Equity Solution - AccendoWave Benchmarks Pain Data with Machine Learning Technology. AccendoWave does real-time objective individual assessment of patient pain. For use with telemedicine (as you see only have the patient and loose all the non verbal pain cues), Hospital at Home, Home Care, Clinic or Urgent Care site.

AccendoWave utilizes full spectrum brain analysis and deep learning algorithms to objectively measure pain. We have the largest Global Real-Time Benchmarked Pain Database. 

Health care has a pain bias problem. Pain is one of the most subjective measures in all of medicine - and thus subject to bias. There is an extensive body of research that shows bias: women and pain, ethnicity and pain, and seniors and pain. For many in these groups - their #1 complaint is that their pain isn't believed. An unbiased medical technology which can validate patient pain is critical given Provider Health Equity pledges.

Individual patient pain can be validated and compared to a pain database for use with pain care pathways. 

AccendoWave, a Pain Data Company with machine learning pain measurement & management technology. 

AccendoWave, a Top 4 Global Best in Class Health Equity Solution and Top 15 Global Best in Class Remote Monitoring Company, benchmarks pain data (specialty, gender, age) with machine learning technology to eliminate bias, improve outcomes and reduce health care costs. Incubated by HCA - Samsung and AT&T are our partners.

AccendoWave has nine objective pain datbases (Women's Health, Oncology, Labor & Delivery, Emergency Room, Ortho/Neuro, Med/Surg, ICU, Senior, Adults). 

Pain is the primary reason patients access healthcare - so pain is a primary driver of health care cost. Pain levels don't show up in claims data nor can objective pain levels be extracted from EHR's. So Employers/Health Plans/Hospitals/Government have no visibility into or data on the primary driver of health care costs.  

Pain has a bias problem. There is extensive research & RWD showing bias: women and pain, ethnicity and pain, seniors and pain. 

The real world data from our health care systems is crushinly similar. #1 complaint of patients of color is that their pain isn't believed. This results in less pain medicine given to these patients and later stage cancer diagnosis.  

Given the new state, health plan and CMS initiatives on health equity, health systems must provide data and focus on this pain bias problem. 

Additionally, a patient whose pain isn't believed doesn't trust their provider or health care system, and their patient experience is a zero. 

AccendoWave provides data and insights to eliminate pain bias, improve care and reduce stakeholder healthcare costs. 

AccendoWave utilizes full spectrum brain analysis and deep learning algorithms to measure & monitor discomfort/pain. AccendoWave has four products: 

1. Digital Opioid Alternative (Hospital & Home) Value Proposition - Reduce Opioid Usage, Reduce Length of Stay, and Improve Patient Satisfaction. Most Cost Effective Choice to Meet The Joint Commission Non Pharma Pain Treatment Modality Requirement. Home - to reduce opioid usage in the transition from hospital to home. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

2. UV Sanitizing & Charging Technology (Hospital) Value Proposition - Infection Control and Simplified Charging for AccendoWave Hospital Technology. 

3. Top 15 Global Best in Class Remote Pain Monitoring Technology. Value Proposition - Data Insight into Pain - A Primary Driver of Cost & Outcomes. *AT&T reimburses for AccendoWave for 30 days post hospital discharge. 

4. Largest Global Real-Time Database on Pain with Nine Seperate Objective Pain Databases. Value Proposition - Objective Pain Benchmarked Data to Address Health Equity, Improve Operational Performance, Reduce Costs, Improve Patient Satisfaction, and Demonstrate Outcomes. 

Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?

AccendoWave is the only company that can remotely objectively measure individual patient pain. The technology can be used in the hospital and to remotely monitor and manage patient pain at home or in non acute care settings.

AccendoWave has the largest global database on pain and offers the only remote pain monitoring solution.

In the sales process, we often hear “Doesn’t Epic (or other EHR) do that?” Rimidi is not built to replace the EHR, but to enhance it by bringing in additional data sets, providing more efficient workflows, and improving the user experience. Rimidi can install and configure its platform within 3-6 weeks which is significantly faster and more cost effective than onsite EHR teams can build and support enhancements to meet clinical needs. Rimidi’s modern technology stack enables rapid cycle innovation and iteration post-go live.

Rimidi’s cardiometabolic platform is most often compared to other Remote Patient Monitoring solutions, but the platform-approach to RPM allows Rimidi to do so much more. Some key differentiators of the Rimidi platform are: (1) tight integration with leading EHRs via SMART on FHIR, (2) the breadth of the comorbid disease states we cover, (3) our incorporations of patient-reported outcomes and social determinants of health measures and (4) our Clinical Decision Support engine. Rimidi’s CDS cards support almost any insight or intervention a client wants: RPM data alerting and interventions, referral management, lab or medication recommendations, clinical trial identification, and more.